bpc-157 synthetic stable gastric pentadecapeptide Heal or Harm: Body Protective Compound-157 in the Gray Zone Stable Gastric Pentadecapeptide BPC 157

Interstitial Cystitis Study (2024): A preliminary trial in 12 patients with interstitial cystitis (a chronic bladder condition) reported resolution of symptoms in 80 - 100% of participants following BPC-157 treatment

G., Kurth, T., Belanger, C., MacFadyen, J., & Gaziano, J

Connective tissues such as tendons and ligaments, which typically demonstrate limited intrinsic healing capacity, have also been examined in relation to BPC-157 activity

10.1016/j.jconrel.2016.08.035 [DOI] [PubMed] [Google Scholar] Xu C., Sun L., Ren F., Huang P., Tian Z., Cui J., et al

Endocannabinoid-mediated metaplasticity in the hippocampus

It can be injected or taken orally